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Abstract The enzyme kynurenine aminotrahsferase (KAT) catalyses the conversion of rkynurenine to kynurenic acid. A combination of polymerase 
chain reaction techniques and hybridization screening was used to isolate a cDNA clone encompassing the entire coding region of KAT from rat 
kidney. Identitication of the cDNA as coding for KAT was based both on the comparison of amino acid sequences obtained from purified rat KAT 
and on the expression of KAT activity in COS-1 cells transfected with the cDNA. RNA blot analysis indicated that RAT mRNA is widely expressed 
in rat tissues. Cultured cells transfected with the cDNA for KAT also showed glutamine transaminase K activity. Based mainly on sequence data, 
these results demonstrate that rat kidney KAT is identical with glutamine trausaminase K. 
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1. introduction 
Indoleamine 2,3-dioxygenase (IDO) (EC 1.13.11.11) opens 
the tryptophan indole ring, initiating the formation of a series 
of compounds collectively called kynurenines [l]. Among these, 
kynurenic acid (KYNA) is known as an endogenous antagonist 
of all three ionotropic excitatory amino acid receptors in the 
mammalian brain [ 11. KYNA has attracted particular attention 
for its ability to block quinolinic acid-induced neurotoxicity 
and seizures [2], to decrease ischemic brain damage and associ- 
ated deficits [3], and to protect against hypoxia-induced cere- 
bral edema [4]. In mammalian peripheral organs, KYNA is 
biosynthesized from L-kynurenine by several rather unspecific 
aminotransferases [5,6]. Studies in the rat brain have shown 
that at physiological kynurenine concentrations a single 
kynurenine aminotransferase (KAT) is responsible for KYNA 
production [7]. In the course of our investigations of KYNA 
metabolism and function [8], we now report the isolation of a 
full length cDNA clone which contains the entire protein cod- 
ing region of rat KAT. 
2. Materials and methods 
2.1. Partial amino acid sequence of rat KAT 
Rat kidney KAT was prepared essentially as described previously [9]. 
The enzyme eluted from a Sephacryl S-200 column was further purified 
by HPLC using a reverse-phase column (SC18, 250 x 4.6 mm, Japan 
Spectra. Co. Ltd). Elution was performed with a gradient of 70% 
(vol/vol) acetonitrile in 0.1% trifluoroacetic acid (TFA) and 0.1% TFA, 
applied for 40 min at a flow rate of 1 ml/min. 500 pmol of HPLC- 
purified rat KAT were then digested by trypsin and CNBr as described 
[lo]. Subsequently, the samples were subjected to reverse-phase HPLC, 
and the resulting polypeptide fragments were identified and collected. 
Peptides 9-25 and 194-225 were obtained by trypsin digestion while 
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peptide 354-367 was obtained after CNBr cleavage. Sequence analysis 
was performed by Edman degradation in a gas-phase sequenator (Ap- 
plied Biosystems, Foster City, CA, USA) [l 11. Cys-203 and Cys-210 in 
peptide 194-225 were determined as carboxymethylcysteine. The first 
two amino acids in peptide 354-367 were not determined ue to high 
background of the first two cycles of the analysis. 
2.2. PCR cloning and library screening 
Total RNA from rat kidney was extracted from small quantities of 
tissue according to the RNAzol method (RNAzol-CinnalBiotex Lab, 
TX, USA). Reverse transcription and PCR were performed as de- 
scribed [12]. Since the relative position of the two tryptic fragments 
obtained from purified rat kidney ICAT (peptides 9-25 and 194225) 
along KAT’s primary structure was unknown, four degenerated 26-bp- 
long oligonucleotides were designed and synthesized using a DNA/ 
RNA synthesizer (380B Applied Biosystems), and the reaction products 
were purified on a Sephadex G-50 column (Nap 25 Column, Pharma- 
cia). The sense orientation oligonucleotide, OligoA: (AAYYT- 
NTGYCARCARCAYGAYGTNGT), and the anti-sense orientation 
oligonucleotide, OligoC: (ACNACRTCRTGYTGYTGRCANAR- 
RTT) based on the peptide sequence Asn-Leu-Cys-Gln-Gln-His-Asp- 
Val-Val (residues 8-16 of peptide 194225), and the sense orientation 
oligonucleotide, OligoB: (ACNGANARRTTYTGRTCXATNCC- 
RTC) and the corresponding anti-sense oligonucleotide, oligoD: 
(GAYGGNATZGAYCARAAYYTNTCNGT), based on the peptide 
sequence Asp-Gly-Ile-Asp-Gln-Am-Leu-Ser-Val (residues 3-l 1 of pep- 
tide 9-25) (N = TCAG; i = TCA; R = AG; Y = TC; X = TGA), were 
svnthesized. The first strand cDNA was divided in two aliauote and 
amplified by PCR. The two oligonucleotide mixtures PCRl: ojigoA and 
oligoD and PCR2 oligoB and oligoC were used as primers in the PCR 
reaction. A specific amplification product was observed only with 
PCRl . The product of the amplification was a DNA molecule of about 
550 bp. The PCRl-amplification product was gel-purified and se- 
quenced by the dideoxy chain termination method [13], using Sequenase 
(United States Biochemicals Corp., Cleveland, OH). The PCR product 
was used as a probe to screen under stringent conditions a &tll rat 
kidney cDNA library (Clontech, Palo Alto, CA). The phage DNA from 
the positive plaques was digested with EcoRI, and the insert was ligated 
to the EcoRI site of pUC18. Sequencing was carried out with universal 
and forward primer and subsequently with a series of synthetic oligonu- 
cleotide primers according to the dideoxy termination method. 
2.3. Expression of cloned KAT in COS-I cells 
The expression plasmid encoding rat KAT was constructed as fol- 
lows. PCR amplification was performed using two specific oligonucle- 
otides with X/z01 linkers. The sense orientation oligonucleotide 
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(S-TGTCCTCGAGACCATGACCAAACGGCTGCAGGCTCGG- 
A-3’) began at +4 of the coding strand, whereas the antisense-orienta- 
tion oligonucleotide (S-GTACCTCGAGTCAGGGTTGGAGCTC- 
TTTCCACTTG-31 corndemented the seouence startiner f om the end 
of the coding sequence. ?‘he XhoI-digested fragment, alter being con- 
trolled by sequencing, was cloned into the X/WI site of a pSVL expres- 
sion vector (Phannacia biotechnology). COS-1 cells were transfected 
with 10 pg of pSVL-KAT plasmid by the calcium phosphate method 
[14]. 72 hours after transfection, cells were disrupted by freezing and 
thawing. After centrifugation (15,000 g for 30 min), the supernatant 
was used for the determination of KAT and glutamine transminase K
(GTK) activities. 
2.4. Transaminase assays 
The reaction mixture (100 ,ul) contained 70 ,uM pyridoxal phosphate, 
5 mM pyruvate, 3 mM kynurenine, and enzyme preparation in 0.17 M 
potassium phosphate buffer, pH 8.1, and was incubated at 37’C for 30 
min. The reaction was stopped by adding 20~150% trichloroacetic acid, 
and the precipitate was removed by centrifugation. The KYNA content 
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of the supernatant was analyzed by HPLC (flow rate: 1 ml/mm) using 
a Cl8 column (Vydac 201TP54, 25 x 4.6 cm x mm) equilibrated with 
5 mM acetic acid, 5% methanol, 0.1% heptane sulfonic acid, pH 3.0 
KYNA was eluted with 50 mM acetic acid, 5% methanol, 0.5% heptane 
sulfonic acid, pH 4.5, and its absorbance was measured at 243 nm. 
GTK activity was measured in the same cell extract as described previ- 
ously [15], using 10 mM phenylalanine and 5 mM cc-keto-y-methiolbu- 
tyrate. 
3. Results and discussion 
Positive plaques were isolated by the screening of approx. 
5 x lo5 plaques from a rat kidney cDNA library, and the inserts 
were analyzed by restriction analysis and DNA sequencing. 
Fig. 1 shows the full-length cDNA sequence of rat KAT. The 
partial amino acid sequences obtained from the NH, terminus 
and internal peptides of the purified rat kidney enzyme, includ- 
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Fig. 1. Nucleotide sequence of KAT cDNA and its derived amino acid sequence. Regions of alignment with trypsin and CNBr cleavage fragments 
as well as N-terminal sequence are underlined. Note that peptide 9-25 is included in the N-terminal sequence. The N-terminal was determined after 
PCR cloning. The putative PLP binding site is underlined twice. Triplets differing from the rat B-lyase sequence [16] are boxed. 
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ing a total of IO amino acids, were consistent with the deduced 
amino acid sequence of the cDNA. The predicted molecular 
weight (47,743) was in good agreement with that determined for 
the native rat kidney enzyme [9]. The nucleotide sequence sur- 
rounding the first methionine corresponded well to the Kozak’s 
consensus sequence for an eukaryotic initiation site, so that it 
is likely that translation begins at the ATG site shown in Fig. 
1. The first amino acid of mature KAT determined by protein 
sequencing is leucine. It is therefore likely that removal of four 
amino acids at the N-terminus of rat KAT occurs in vivo due 
to the proteolytic cleavage of endopeptidases acting at dibasic 
residues. A typical polyadenylation signal, AATAAA, was ob- 
served in the 3’untranslated region at nucleotides 1628-1633. 
A consensus sequence for pyridoxal phosphate (PLP) binding 
[15] was present at amino acids 244-249 of the deduced KAT 
sequence. Northern gel analysis of multiple tissues identified 
heterogeneous rat KAT transcripts. A 2.3 kb major mRNA 
was expressed, albeit at different levels, in all tissues except 
testis where a slightly larger mRNA could be detected. Two 
bands of about 2.3 and 3.0 kb, at a relative abundance of about 
3 : 1, were detected in mRNA extracted from liver. To assess 
functional activity of the cDNA, rat KAT was subcloned into 
a mammalian expression vector and transfected to COS-1 cells. 
A significant increase in KAT activity was observed in sense- 
transfected cells as compared to antisense-transfected control 
cells (Fig. 3B). Comparison of the nucleotide sequence with the 
GenBank DNA sequence database indicated that the sequence 
was virtually identical with rat kidney cytosolic cysteine conju- 
gate /I-lyase [ 161. Two differences, likely explained by rat strain 
heterogeneity, were observed: alanine instead of arginine (resi- 
due 107) and valine instead of isoleucine (residue 177). Since 
cysteine conjugate /I-lyase possesses GTK activity [ 171, KAT- 
positive COS-I cells transfected with the sense cDNA were 
examined for the presence of GTK activity (Fig. 3A). The 
results demonstrated the identity of KAT and GTK. Molecular 
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Fig. 3. Transaminase activities in transfected cells. Enzyme activities are 
expressed per mg of protein. A, glutamine transaminase K activity; B, 
kynurenine transaminase activity. Each value is the mean of three 
experiments. 
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probes derived from the cloned cDNA can therefore be ex- 
pected to provide useful tools for the further study of the role 
of this multifunctional enzyme en physiology and pathology. 
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